Phase I/II study of gefitinib and capecitabine in patients with colorectal cancer.
Jimeno A, Grávalos C, Escudero P, Sevilla I, Vega-Villegas ME, Alonso V, Juez I, García-Carbonero R, Bovio H, Colomer R, Cortés-Funes H.
Jimeno A, et al.
Clin Transl Oncol. 2008 Jan;10(1):52-7. doi: 10.1007/s12094-008-0153-5.
Clin Transl Oncol. 2008.
PMID: 18208793
Clinical Trial.